VISUAL IMPAIRMENT
Clinical trials for VISUAL IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new VISUAL IMPAIRMENT trials appear
Sign up with your email to follow new studies for VISUAL IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye implant for diabetes: risky experiment or new hope?
Disease control TerminatedThis study aimed to test if placing insulin-producing cells into the front of the eye is safe for people with type 1 diabetes. Only 6 participants were planned, all needing lifelong immune-suppressing drugs. The study was withdrawn before starting, so no results are available.
Matched conditions: VISUAL IMPAIRMENT
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
AI eye check: could a computer spot vision problems better than current tests?
Diagnosis OngoingThis study tests whether an AI-assisted screening model can more accurately detect visual impairment in people aged 50 and older compared to traditional methods. Researchers will compare referral accuracy, time per screening, and costs. Participants will undergo one of the two sc…
Matched conditions: VISUAL IMPAIRMENT
Phase: NA • Sponsor: Singapore Eye Research Institute • Aim: Diagnosis
Last updated May 26, 2026 04:09 UTC
-
Study reveals top causes of blindness in upper egypt
Knowledge-focused OngoingThis study reviewed 2000 people in Upper Egypt who applied for a visual disability certificate between 2020 and 2024. Researchers want to find out which eye diseases are most common and which ones cause the most vision loss. The goal is to understand the main causes of visual imp…
Matched conditions: VISUAL IMPAIRMENT
Sponsor: New Valley University • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
New eye Drug's Real-World impact under scrutiny in 2,500-Patient study
Knowledge-focused OngoingThis study watches how well aflibercept 8 mg works in real life for people with vision loss from age-related macular degeneration or diabetic eye swelling. Researchers will track vision changes over 12 months using routine doctor visits. No extra tests or visits are required—just…
Matched conditions: VISUAL IMPAIRMENT
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC